Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 9Carcinoma, Merkel Cell 7Neoplasm Metastasis 6Breast Neoplasms 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Melanoma 4Urethral Neoplasms 3Ureteral Neoplasms 3Skin Neoplasms 3Carcinoma, Renal Cell 3Ovarian Neoplasms 2Neuroendocrine Tumors 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thymoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Peritoneal Neoplasms 1Penile Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Motor Activity 1Microsatellite Instability 1

Interventions

Nivolumab 2Ipilimumab 2pembrolizumab 1entinostat 1cabozantinib 1bintrafusp alfa protein, human 1avelumab 1Vaccines, Synthetic 1Specimen Handling 1Psychiatric Nursing 1Platinum 1Physical Therapy Modalities 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Cisplatin 1CTLA-4 Antigen 1Biopsy 1BAY 1895344 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Penile Neoplasms × avelumab × Clear all
NCT03391479 2025-12-18

A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy

University Health Network, Toronto

Phase 2 Active not recruiting
25 enrolled
Genitourinary

Neoplasm Metastasis, Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡